Blood Pressure Drug Reduces Risk Of Cardiovascular Disease and Stroke

According to a press release by the AHA, a new study published in Hypertension: Journal of the American Heart Association has shown that a long-acting ACE inhibitor used to reduce blood pressure significantly decreased the risk for cardiovascular disease, including stroke, in normal weight, overweight and obese patients. Obese patients, who had higher initial blood pressure rates, gained the greatest benefit from blood pressure-lowering therapy.
In the United States, an estimated 81 million people suffer from cardiovascular disease, according to the American Heart Association.

ASweetLife Team

USDA Panel Reduces Added Sugar Recommendations. Is it… The United States Dietary Advisory Committee (DGAC) has released its scientific report, the latest step in the slow process of revising the federal nutrition guidelines. If there’s a headline for…
Dr. Fung: Why Obesity and Diabetes Increase Cancer Risk Dr. Jason Fung is widely known as an advocate for the technique of intermittent fasting in patients hoping to reverse or prevent diabetes and obesity. He has written several books…
What is Leptin? And How it May Impact Covid-19 Risk Factors You May Be Leptin-Resistant. Here’s Why It’s Important. In the diabetes world, leptin doesn’t get nearly the attention that other hormone, insulin, does. But leptin—called a master metabolic regulator—is pretty…
New Study Shows Covid-19 Risk Higher in Type 2 Diabetes than… A new study of people with diabetes hospitalized with COVID-19 has found that Type 1 diabetes may be significantly less dangerous than Type 2 diabetes. The paper, titled “Type 1…
Why Doggie Diabetes is a Risk Factor for Human Owners Researchers: Doggie Diabetes is a Bad Sign for Dog Owners Bless the researchers of Uppsala University, Sweden, who are asking the important questions: if your pet has diabetes, is it…